134 related articles for article (PubMed ID: 20385509)
21. A novel dominant mutation of the Nav1.4 alpha-subunit domain I leading to sodium channel myotonia.
Petitprez S; Tiab L; Chen L; Kappeler L; Rösler KM; Schorderet D; Abriel H; Burgunder JM
Neurology; 2008 Nov; 71(21):1669-75. PubMed ID: 19015483
[TBL] [Abstract][Full Text] [Related]
22. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.
Michiels JJ; te Morsche RH; Jansen JB; Drenth JP
Arch Neurol; 2005 Oct; 62(10):1587-90. PubMed ID: 16216943
[TBL] [Abstract][Full Text] [Related]
23. A new Nav1.7 mutation in an erythromelalgia patient.
Estacion M; Yang Y; Dib-Hajj SD; Tyrrell L; Lin Z; Yang Y; Waxman SG
Biochem Biophys Res Commun; 2013 Mar; 432(1):99-104. PubMed ID: 23376079
[TBL] [Abstract][Full Text] [Related]
24. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.
Han C; Yang Y; de Greef BT; Hoeijmakers JG; Gerrits MM; Verhamme C; Qu J; Lauria G; Merkies IS; Faber CG; Dib-Hajj SD; Waxman SG
Neuromolecular Med; 2015 Jun; 17(2):158-69. PubMed ID: 25791876
[TBL] [Abstract][Full Text] [Related]
25. A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia.
Fischer TZ; Gilmore ES; Estacion M; Eastman E; Taylor S; Melanson M; Dib-Hajj SD; Waxman SG
Ann Neurol; 2009 Jun; 65(6):733-41. PubMed ID: 19557861
[TBL] [Abstract][Full Text] [Related]
26. Kinetic modeling of Nav1.7 provides insight into erythromelalgia-associated F1449V mutation.
Gurkiewicz M; Korngreen A; Waxman SG; Lampert A
J Neurophysiol; 2011 Apr; 105(4):1546-57. PubMed ID: 21289137
[TBL] [Abstract][Full Text] [Related]
27. Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation.
Skeik N; Rooke TW; Davis MD; Davis DM; Kalsi H; Kurth I; Richardson RC
Vasc Med; 2012 Feb; 17(1):44-9. PubMed ID: 22033523
[TBL] [Abstract][Full Text] [Related]
28. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
[TBL] [Abstract][Full Text] [Related]
29. Erythermalgia: molecular basis for an inherited pain syndrome.
Waxman SG; Dib-Hajj S
Trends Mol Med; 2005 Dec; 11(12):555-62. PubMed ID: 16278094
[TBL] [Abstract][Full Text] [Related]
30. Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment.
Nathan A; Rose JB; Guite JW; Hehir D; Milovcich K
Pediatrics; 2005 Apr; 115(4):e504-7. PubMed ID: 15741349
[TBL] [Abstract][Full Text] [Related]
31. Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Na
Yang Y; Adi T; Effraim PR; Chen L; Dib-Hajj SD; Waxman SG
Br J Pharmacol; 2018 Jun; 175(12):2261-2271. PubMed ID: 28658526
[TBL] [Abstract][Full Text] [Related]
32. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile.
McDonnell A; Schulman B; Ali Z; Dib-Hajj SD; Brock F; Cobain S; Mainka T; Vollert J; Tarabar S; Waxman SG
Brain; 2016 Apr; 139(Pt 4):1052-65. PubMed ID: 26920677
[TBL] [Abstract][Full Text] [Related]
33. A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons.
Estacion M; Gasser A; Dib-Hajj SD; Waxman SG
Exp Neurol; 2010 Aug; 224(2):362-8. PubMed ID: 20420834
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a familial case with primary erythromelalgia from Taiwan.
Lee MJ; Yu HS; Hsieh ST; Stephenson DA; Lu CJ; Yang CC
J Neurol; 2007 Feb; 254(2):210-4. PubMed ID: 17294067
[TBL] [Abstract][Full Text] [Related]
35. Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia.
Choi JS; Cheng X; Foster E; Leffler A; Tyrrell L; Te Morsche RH; Eastman EM; Jansen HJ; Huehne K; Nau C; Dib-Hajj SD; Drenth JP; Waxman SG
Brain; 2010 Jun; 133(Pt 6):1823-35. PubMed ID: 20478850
[TBL] [Abstract][Full Text] [Related]
36. Erythromelalgia: a hereditary pain syndrome enters the molecular era.
Waxman SG; Dib-Hajj SD
Ann Neurol; 2005 Jun; 57(6):785-8. PubMed ID: 15929046
[TBL] [Abstract][Full Text] [Related]
37. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy.
Cummins TR; Dib-Hajj SD; Waxman SG
J Neurosci; 2004 Sep; 24(38):8232-6. PubMed ID: 15385606
[TBL] [Abstract][Full Text] [Related]
38. Chronic non-paroxysmal neuropathic pain - Novel phenotype of mutation in the sodium channel SCN9A gene.
Dabby R; Sadeh M; Gilad R; Lampl Y; Cohen S; Inbar S; Leshinsky-Silver E
J Neurol Sci; 2011 Feb; 301(1-2):90-2. PubMed ID: 21094958
[TBL] [Abstract][Full Text] [Related]
39. Atypical changes in DRG neuron excitability and complex pain phenotype associated with a Na
Huang J; Mis MA; Tanaka B; Adi T; Estacion M; Liu S; Walker S; Dib-Hajj SD; Waxman SG
Sci Rep; 2018 Jan; 8(1):1811. PubMed ID: 29379075
[TBL] [Abstract][Full Text] [Related]
40. A pore-blocking hydrophobic motif at the cytoplasmic aperture of the closed-state Nav1.7 channel is disrupted by the erythromelalgia-associated F1449V mutation.
Lampert A; O'Reilly AO; Dib-Hajj SD; Tyrrell L; Wallace BA; Waxman SG
J Biol Chem; 2008 Aug; 283(35):24118-27. PubMed ID: 18550534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
